Company Filing History:
1 out of 313 
1 out of 1 Years Active: 2023
Title: Marco Petrillo: Innovator in Cancer Treatment
Introduction
Marco Petrillo is a notable inventor based in Campobasso, Italy. He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic agents.
Latest Patents
Petrillo holds a patent for "NEK6 kinase inhibitors useful for the treatment of solid tumors." This invention focuses on mitotic kinases that regulate the dynamics of centrosomes and the functions of the mitotic spindle, which are potential targets for antitumor therapy. The patent identifies molecules with inhibitory activity on NEK6 and describes their use in compositions for treating tumors, both as monotherapy and in combination with other drugs. He has 1 patent to his name.
Career Highlights
Throughout his career, Marco Petrillo has worked with esteemed organizations such as the National Research Council of Italy (Consiglio Nazionale Delle Ricerche) and Molipharma S.r.l. His work has been instrumental in advancing the understanding and treatment of cancer.
Collaborations
Petrillo has collaborated with notable colleagues, including Maria Cristina De Rosa and Davide Pirolli. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
Marco Petrillo's innovative work in developing NEK6 kinase inhibitors showcases his commitment to improving cancer treatment. His contributions to the field are invaluable and highlight the importance of research in the fight against cancer.